URGN: Pendapatan lan volume dodolan UroGen Pharma

Lambang korporat lan logo urogen.com (URGN)

UroGen Pharma Ltd. (URGN) is implementing automation in the production of sterile hydrogels, complementing this with the digitalization of clinical trial reporting. The company's sales dynamics demonstrate a long-term trend, where the current metric remains around 0.25. Management is effectively commercializing innovative therapies for bladder cancer, consistently expanding the medical evidence base for its drugs.

UroGen Pharma (URGN) - Pendapatan perusahaan saka 04.07.2022 nganti 17.11.2026

Rincian metrik komprehensif lan analitis urogen.com (URGN)

- rega pasar lan target rega analis:
Analisis komprehensif perusahaan:UroGen Pharma URGN
Produk seri UroGen Pharma Ltd.

Steady revenue growth confirms the long-term sustainability of UroGen Pharma Ltd. (URGN) for strategic capital. This indicator captures actual cash flow from sales, excluding accounting estimates. An analysis of corporate sales allows for an assessment of business scaling rates and the precision of market positioning. This price action reflects the expansion of innovative gel-based drugs within specialized clinics. The growth of the professional center network converts directly into an upward trend for this metric.

Perusahaan pesaing

Pendapatan perusahaan ONC|Pendapatan lan volume dodolan HALO|RVMD (Revolution Medicines, Inc.) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Ascentage Pharma Corp AAPG|Total volume dodolan perusahaan CG Oncology, Inc.|bicara.com - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan PSNL (personalis.com)|Erasca Inc (ERAS) - Pendapatan perusahaan|Dodolan perusahaan Delcath Systems|YMAB (YmAbs) - Pendapatan lan volume dodolan|AURA: Pendapatan dodolan perusahaan|Pendapatan perusahaan Candel Therapeutics, Inc. (CADL)|Pendapatan lan volume dodolan Accuray (ARAY)|Pendapatan perusahaan SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Total pendapatan perusahaan|CTOR - Pendapatan perusahaan|HURA: Pendapatan perusahaan|TARA (Protara) - Dodolan perusahaan|Fate Therapeutics, Inc. - Pendapatan dodolan perusahaan|WHWK (aadibio.com) - Pendapatan lan volume dodolan|TCRX: Pendapatan dodolan perusahaan|Pendapatan perusahaan Champions Oncology (CSBR)|XBiotech - Volume dodolan perusahaan|Pendapatan perusahaan CEL-SCI CVM|Pendapatan reged perusahaan OS Therapies (OSTX)|Radiopharm Theranostics Limited - Pendapatan lan volume dodolan|Total pendapatan perusahaan Artiva Biotherapeutics|ANL (adlainortye.com) - Dodolan perusahaan|Dodolan perusahaan Veru Pharma|TPST (Tempest Therapeutics Inc) - Pendapatan lan volume dodolan|Xilio Therapeutics, Inc. (XLO) - Pendapatan reged perusahaan|Pendapatan perusahaan Enochian BioSciences (RENB)|MURA: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan KAPA (kairospharma.com)|Pendapatan reged perusahaan OnKure (OKUR)|CytoMed Therapeutics Ltd - Pendapatan lan volume dodolan|curis.com (CRIS) - Dodolan perusahaan|Apollomics Corp (APLM) - Pendapatan perusahaan|Tharimmune - Pendapatan dodolan perusahaan|ADVB (Advanced Biomed Corp) - Pendapatan lan volume dodolan|Dodolan perusahaan Genprex, Inc (GNPX)|Pendapatan lan volume dodolan CLDI|SBFM: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan XBIO (xeneticbio.com)|Pendapatan lan volume dodolan Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Pendapatan lan volume dodolan|Total pendapatan perusahaan American Oncology Network, Inc.|BGNE: Pendapatan lan volume dodolan|Dodolan perusahaan checkpointtx.com|Pendapatan perusahaan Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Pendapatan reged perusahaan|Pendapatan perusahaan Ikena (IKNA)|NTBL - Total pendapatan perusahaan|Pendapatan perusahaan viracta.com VIRX|morphosys.com (MOR) - Total pendapatan perusahaan|NAYA Biosciences Inc - Pendapatan lan volume dodolan|AAPGV: Pendapatan perusahaan